Primary nephrotic syndrome in adults is characterized by severe proteinuria and hypoalbuminemia. This was the first clinical trial to test rituximab in adult-onset frequently relapsing nephrotic ...
Rituximab (Rituxan) prevented relapse in patients with adult-onset frequently relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS), a randomized trial showed. Among 66 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback